| Molecular technologies play an important role in
evolving medicine. Monitoring genes and their activities can accurately
reveal individual health and disease conditions. We develop and
market predictive and personalized medicine products. Our technology
core focuses on protecting and identifying genes in peripheral blood
samples.
TheraLead™, a blood
based molecular assay, is available via Clinicogen.
The coronavirus disease outbreak began in December 2019. It is
spreading rapidly throughout the world, becoming pandemic.
GS™
COVID-19 Real-Time PCR Kit is a highly sensitive assay
that directly detects the viral genome (RNA) using real-time
RT-PCR, runs on the Applied Biosystems™ 7500 Fast Dx
Real-Time PCR Instrument. |
 |
GS™ COVID-19
Real-Time PCR Kit was granted by the FDA Emergency Use Authorization
for high throughput COVID-19 RT-PCR Diagnostic on April 16, 2020.
| Cat # |
Product Name |
Description |
Size |
Price |
2702-22 |
GS™ COVID-19 Real-Time PCR Kit - 22 |
Provide all-in-one master mix including
cDNA synthesis, PCR mix, primers and probe of each gene. |
22
samples |
Request a quote |
2702-94 |
GS™ COVID-19 Real-Time PCR Kit - 94 |
Provide all-in-one master mix including
cDNA synthesis, PCR mix, primers and probe of each gene. |
94
samples |
Request a quote |
For use under the Emergency Use Authorization (EUA)
only
For in vitro diagnostic use
For more up-to-date information on the current coronavirus
outbreak, visit the WHO
or CDC
websites.
| 